Drug Price Trends for FT MUCUS RELIEF ER

Average Pharmacy Cost for FT MUCUS RELIEF ER

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
FT MUCUS RELIEF ER 600 MG TAB	70677-1013-01	0.33120	EACH	2025-03-19
FT MUCUS RELIEF ER 600 MG TAB	70677-1052-01	0.33120	EACH	2025-03-19
FT MUCUS RELIEF ER 1,200 MG TB	70677-1051-01	0.46044	EACH	2025-03-19
FT MUCUS RELIEF ER 600 MG TAB	70677-1052-01	0.32454	EACH	2025-02-19
FT MUCUS RELIEF ER 600 MG TAB	70677-1013-01	0.32454	EACH	2025-02-19

Market Analysis and Price Projections for FT MUCUS RELIEF ER

Introduction to FT MUCUS RELIEF ER

FT MUCUS RELIEF ER, containing the active ingredient guaifenesin, is an expectorant used to relieve chest congestion and make it easier to cough up mucus. This medication is commonly prescribed for conditions such as bronchitis, bronchiectasis, and cough.

Market Overview of Expectorant Drugs

The global market for expectorant drugs, including guaifenesin, is experiencing significant growth. The expectorant drugs market was valued at US$ 16,384.6 million in 2023 and is projected to reach US$ 38,455.4 million by 2034, growing at a Compound Annual Growth Rate (CAGR) of 4.3% from 2024 to 2034[3].

Guaifenesin Market Specifics

The global guaifenesin market, specifically, is forecasted to reach USD 95 million by 2027, growing at a CAGR of approximately 3.1% from 2022 to 2027. This growth is driven by the increasing demand for cough treatment drugs, chest congestion medications, and other respiratory health treatments[1][4].

Price Trends for FT MUCUS RELIEF ER

Current Pricing

As of the latest data, the prices for FT MUCUS RELIEF ER vary based on the dosage and quantity. For example:

• The cost for QC MUCUS RELIEF ER 1,200 MG TB is around $0.47210 per unit.
• The cost for QC MUCUS RELIEF ER 600 MG TAB is approximately $0.34521 per unit[1].

General Pricing for Guaifenesin Products

For a broader perspective, the cost for Mucus Relief 400 mg oral tablets, another guaifenesin product, is around $11 for a supply of 60 tablets. This price can vary depending on the pharmacy and any discounts applied[2].

Factors Influencing Pricing

Demand and Supply

The demand for guaifenesin is increasing due to its widespread use in treating respiratory conditions. This demand, particularly in multispecialty hospitals and clinics, drives the market growth and can influence pricing[4].

Pharmaceutical Sector Growth

The Indian pharmaceutical sector, for instance, is expected to reach USD 65 billion by 2024 and around USD 120-130 billion by 2030. Such growth in the pharmaceutical sector can impact the pricing of guaifenesin products[4].

Government Initiatives and Health Awareness

Government initiatives to improve respiratory health, especially post-pandemics like COVID-19, have highlighted the importance of expectorants. This increased awareness and regulatory support can lead to higher demand and potentially stable or increasing prices[3].

Market Segmentation and Growth Drivers

By Application

The cough treatment drug segment is the fastest growing, expected to grow with a CAGR of around 3.7% during the forecast period. Guaifenesin's use in various forms such as syrups, tablets, and granules for pediatric and geriatric populations is a significant growth driver[4].

By End-Use Industry

Multispecialty hospitals hold the largest market share, with over 57% in 2021. The increasing application of guaifenesin in hospitals for treating cough, chest congestion, and other respiratory issues is a major growth factor[4].

Geographical Distribution

The market is segmented geographically, with North America, Europe, Asia-Pacific, South America, the Middle East, and Africa being key regions. The growth in these regions is driven by the increasing prevalence of respiratory diseases and advancements in healthcare infrastructure[4].

Challenges and Opportunities

Availability of Substitutes

One of the major challenges facing the guaifenesin market is the availability of substitute products. However, guaifenesin's effectiveness in thinning mucus and its widespread use in various formulations mitigate this challenge to some extent[4].

Potential Side Effects

Another challenge is the potential side effects associated with guaifenesin, which can impact consumer preference. However, the benefits of guaifenesin in treating respiratory conditions often outweigh these risks[4].

Price Projections

Given the market trends and growth drivers, here are some price projection insights:

• Short-Term Projections: Prices for FT MUCUS RELIEF ER are likely to remain stable or see a slight increase due to the consistent demand for expectorant drugs.
• Long-Term Projections: With the expectorant drugs market projected to grow at a CAGR of 4.3% from 2024 to 2034, prices for guaifenesin products, including FT MUCUS RELIEF ER, may see a gradual increase over the next decade.

Key Takeaways

• The global guaifenesin market is growing due to increasing demand for cough treatment and chest congestion medications.
• FT MUCUS RELIEF ER prices are influenced by market demand, pharmaceutical sector growth, and government health initiatives.
• The market is segmented by application, end-use industry, and geography, with multispecialty hospitals being a major driver.
• Challenges include the availability of substitutes and potential side effects, but the benefits of guaifenesin in treating respiratory conditions are significant.

FAQs

1. What is FT MUCUS RELIEF ER used for?

FT MUCUS RELIEF ER is used to relieve chest congestion and make it easier to cough up mucus, commonly treating conditions such as bronchitis and cough.

2. How is the global guaifenesin market projected to grow?

The global guaifenesin market is forecasted to reach USD 95 million by 2027, growing at a CAGR of approximately 3.1% from 2022 to 2027[1][4].

3. What are the key drivers of the guaifenesin market?

Key drivers include increasing demand for cough treatment drugs, advancements in healthcare infrastructure, and government initiatives to improve respiratory health[3][4].

4. Are there any challenges facing the guaifenesin market?

Yes, challenges include the availability of substitute products and potential side effects associated with guaifenesin[4].

5. How do prices for FT MUCUS RELIEF ER compare to other guaifenesin products?

Prices for FT MUCUS RELIEF ER are comparable to other guaifenesin products, with costs ranging from $0.34521 to $0.47210 per unit, depending on the dosage and quantity[1][2].

Cited Sources

1. DrugPatentWatch: Drug prices and trends for QC MUCUS RELIEF ER[1].
2. Drugs.com: Mucus Relief Prices, Coupons, Copay Cards & Patient Assistance[2].
3. Future Market Insights: Global Expectorant Drugs Market Growth Projection 2024-2034[3].
4. IndustryARC: Guaifenesin Market Size Report, 2022-2027[4].